Date Filed | Type | Description |
08/09/2023 |
10-Q
| Quarterly Report for the period ended July 2, 2023 |
08/01/2023 |
8-K
| Quarterly results |
07/21/2023 |
11-K/A
| Form 11-K/A - Annual report of employee stock purchase, savings and similar plans: [Amend] |
06/16/2023 |
4
| Gonzales Anita (Please See Remarks) has filed a Form 4 on REVVITY, INC.
Txns:
| Granted 329 shares
@ $0 Granted 947 options to buy
@ $116.36, valued at
$110.2k
|
|
06/16/2023 |
3
| Gonzales Anita (Please See Remarks) has filed a Form 3 on REVVITY, INC. |
06/12/2023 |
SC 13G/A
| T. Rowe Price Investment Management, Inc. reports a 10.2% stake in REVVITY INC |
05/31/2023 |
SD
| Form SD - Specialized disclosure report: |
05/12/2023 |
10-Q
| Quarterly Report for the period ended April 2, 2023 |
05/11/2023 |
8-K
| Quarterly results |
04/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/13/2023 |
144
| Form 144 - Report of proposed sale of securities: |
04/13/2023 |
4
| Okun Andrew (Please See Remarks) has filed a Form 4 on PERKINELMER INC
Txns:
| Sold 1,851 shares
@ $135.01, valued at
$249.9k
Sold 3,146 shares
@ $135.29, valued at
$425.6k
Exercised 318 options to buy
@ $96.06, valued at
$30.5k
Exercised 701 options to buy
@ $96.06, valued at
$67.3k
|
|
03/31/2023 |
4
| Krakowiak Maxwell (Please See Remarks) has filed a Form 4 on PERKINELMER INC
Txns:
| Sold 322 shares
@ $130, valued at
$41.9k
|
|
03/29/2023 |
144
| Form 144 - Report of proposed sale of securities: |
03/22/2023 |
4
| Tereau Daniel R (Please See Remarks) has filed a Form 4 on PERKINELMER INC
Txns:
| Exercised 3,750 shares
@ $52.65, valued at
$197.4k
Sold 15 shares
@ $121.69, valued at
$1.8k
Sold 5,122 shares
@ $123.37, valued at
$631.9k
Sold 5,304 shares
@ $124.01, valued at
$657.7k
Sold 300 shares
@ $124.79, valued at
$37.4k
Exercised 3,750 options to buy
@ $0 |
|
03/20/2023 |
144
| Form 144 - Report of proposed sale of securities: |
03/17/2023 |
4
| Krakowiak Maxwell (Please See Remarks) has filed a Form 4 on PERKINELMER INC
Txns:
| Paid exercise price by delivering 21 shares
@ $122.54, valued at
$2.6k
|
|
03/08/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
03/08/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
03/08/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
03/01/2023 |
10-K
| Annual Report for the period ended January 1, 2023 |
02/14/2023 |
SC 13G/A
| Select Equity Group, L.P. reports a 7.7% stake in PerkinElmer, Inc. |
02/14/2023 |
SC 13G/A
| T. Rowe Price Investment Management, Inc. reports a 7.4% stake in PERKINELMER INC |
02/14/2023 |
8-K
| Quarterly results |
02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/09/2023 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
12/23/2022 |
4
| Vohra Tajinder S (Please See Remarks) has filed a Form 4 on PERKINELMER INC
Txns:
| Sold 362 shares
@ $140.567, valued at
$50.9k
Sold 712 shares
@ $142.5, valued at
$101.5k
Sold 588 shares
@ $143.466, valued at
$84.4k
Sold 580 shares
@ $139.206, valued at
$80.7k
Sold 673 shares
@ $140.372, valued at
$94.5k
Sold 410 shares
@ $141.124, valued at
$57.9k
Exercised 1,662 options to buy
@ $48.975, valued at
$81.4k
Exercised 1,663 options to buy
@ $48.975, valued at
$81.4k
|
|
12/23/2022 |
4
| Singh Prahlad R. (Please See Remarks) has filed a Form 4 on PERKINELMER INC
Txns:
| Sold 14,087 shares
@ $140.516, valued at
$2M
Sold 100 shares
@ $141.05, valued at
$14.1k
Exercised 14,187 options to buy
@ $48.975, valued at
$694.8k
|
|
12/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|